Our editors also may be in touch with follow-up questions. Ozempic is a brand-name version of semaglutide, an injectable glucagon-like peptide-1 (GLP-1) receptor agonist medication. One of the ...
Steve Christo - Corbis/Corbis via Getty; Getty It has been theorized that Ozempic could potentially help with substance abuse disorders due to the way it works in the brain. Now the first clinical ...
One of the medicines, naltrexone, has shown a small effect size on alcohol-use disorder, Hendershot told CNN. The semaglutide trial showed effect sizes “in the medium to large range,” he said ...
(Reuters) - Novo Nordisk’s blockbuster GLP-1 diabetes drug Ozempic led to improvements in some measures of alcohol use disorder in a small trial, researchers reported on Wednesday. The 48 ...
The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results